195 related articles for article (PubMed ID: 23793934)
1. Identification of miR-7 as an oncogene in renal cell carcinoma.
Yu Z; Ni L; Chen D; Zhang Q; Su Z; Wang Y; Yu W; Wu X; Ye J; Yang S; Lai Y; Li X
J Mol Histol; 2013 Dec; 44(6):669-77. PubMed ID: 23793934
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
3. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
[TBL] [Abstract][Full Text] [Related]
6. Identification of miR‑130b as an oncogene in renal cell carcinoma.
Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1902-8. PubMed ID: 26717956
[TBL] [Abstract][Full Text] [Related]
7. miR‑15a‑5p acts as an oncogene in renal cell carcinoma.
Jin L; Li Y; He T; Hu J; Liu J; Chen M; Zhang Z; Gui Y; Mao X; Yang S; Lai Y
Mol Med Rep; 2017 Mar; 15(3):1379-1386. PubMed ID: 28098906
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic miR-100-5p is associated with cellular viability, migration and apoptosis in renal cell carcinoma.
Chen P; Lin C; Quan J; Lai Y; He T; Zhou L; Pan X; Wu X; Wang Y; Ni L; Yang S; Wang T; Lai Y
Mol Med Rep; 2017 Oct; 16(4):5023-5030. PubMed ID: 28765937
[TBL] [Abstract][Full Text] [Related]
9. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma.
Su Z; Ni L; Yu W; Yu Z; Chen D; Zhang E; Li Y; Wang Y; Li X; Yang S; Gui Y; Lai Y; Ye J
Mol Med Rep; 2015 Mar; 11(3):2248-54. PubMed ID: 25405789
[TBL] [Abstract][Full Text] [Related]
11. MiR-411 functions as a tumor suppressor in renal cell cancer.
Zhang X; Zhang M; Cheng J; Lv Z; Wang F; Cai Z
Int J Biol Markers; 2017 Oct; 32(4):e454-e460. PubMed ID: 28708205
[TBL] [Abstract][Full Text] [Related]
12. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
Zhang WB; Pan ZQ; Yang QS; Zheng XM
Ir J Med Sci; 2013 Dec; 182(4):621-7. PubMed ID: 23619562
[TBL] [Abstract][Full Text] [Related]
14. Identification of miR‑30b as an oncogene in renal cell carcinoma.
Jin L; Li Y; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2017 Apr; 15(4):1837-1846. PubMed ID: 28259953
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
[TBL] [Abstract][Full Text] [Related]
16. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
Ye ZH; Gui DW
Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
[TBL] [Abstract][Full Text] [Related]
17. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
19. Upregulated microRNA-16 as an oncogene in renal cell carcinoma.
Chen D; Li Y; Yu Z; Su Z; Yu W; Li Y; Yang S; Gui Y; Ni L; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1399-404. PubMed ID: 25815587
[TBL] [Abstract][Full Text] [Related]
20. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
Chen D; Li Y; Yu Z; Li Y; Su Z; Ni L; Yang S; Gui Y; Lai Y
Mol Med Rep; 2015 Aug; 12(2):3061-6. PubMed ID: 25936999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
